{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:43:56Z","timestamp":1792788236674,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Pasteur Institute of Iran, Tehran","award":["2123"],"award-info":[{"award-number":["2123"]}],"id":[{"id":"https:\/\/ror.org\/00wqczk30","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AMB Expr"],"DOI":"10.1186\/s13568-026-02085-7","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T20:54:05Z","timestamp":1783544045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combination antifungal therapy against resistant C. albicans: efficacy and immune response in mice"],"prefix":"10.1186","volume":"16","author":[{"given":"Ali","family":"Taghizadeh-Maleki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farahnaz","family":"Hatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima-Sadat","family":"Seyedjavadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnoush","family":"Asghari-Paskiabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Jahanshiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"2085_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.molimm.2020.05.009","volume":"124","author":"Y Ahmadbeigi","year":"2020","unstructured":"Ahmadbeigi Y, Chirani AS, Soleimani N, Mahdavi M, Goudarzi M (2020) Immunopotentiation of the engineered low-molecular-weight pilin targeting Pseudomonas aeruginosa: a combination of immunoinformatics investigation and active immunization. Mol Immunol 124:70\u201382. https:\/\/doi.org\/10.1016\/j.molimm.2020.05.009","journal-title":"Mol Immunol"},{"issue":"3","key":"2085_CR2","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1128\/AAC.01223-07","volume":"52","author":"L Angiolella","year":"2008","unstructured":"Angiolella L, Stringaro AR, De Bernardis F, Posteraro B, Bonito M, Toccacieli L, Torosantucci A, Colone M, Sanguinetti M, Cassone A, Palamara AT (2008) Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans. Antimicrob Agents Chemother 52(3):927\u2013936. https:\/\/doi.org\/10.1128\/AAC.01223-07","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"2085_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/IDR.S118892","volume":"31","author":"EL Berkow","year":"2017","unstructured":"Berkow EL, Lockhart SR (2017) Fluconazole resistance in Candida species: a current perspective. Infect Drug Resist 31(10):237\u2013245. https:\/\/doi.org\/10.2147\/IDR.S118892","journal-title":"Infect Drug Resist"},{"key":"2085_CR4","unstructured":"Clinical and Laboratory Standards Institute, (2012). reference method for broth dilution antifungal susceptibility testing of yeasts. Document, Fourth Informational Supplement (pp. M27-S24). USA."},{"key":"2085_CR5","unstructured":"Clinical and Laboratory Standards Institute, (2018). epidemiological cutoff values for antifungal susceptibility testing. CLSI Supplement M59, 2nd Edition (pp. 1\u201313). USA."},{"key":"2085_CR6","unstructured":"Clinical and Laboratory Standards Institute, (2020). performance standards for antifungal susceptibility testing of yeasts. CLSI Supplement M60, 2nd Edition (pp. 1\u201311). USA."},{"issue":"6","key":"2085_CR7","doi-asserted-by":"publisher","first-page":"e470","DOI":"10.1016\/S2666-5247(23)00067-8","volume":"4","author":"F Daneshnia","year":"2023","unstructured":"Daneshnia F, de Almeida J\u00fanior JN, Ilkit M, Lombardi L, Perry AM, Gao M, Nobile CJ, Egger M, Perlin DS, Zhai B, Hohl TM, Gabald\u00f3n T, Colombo AL, Hoenigl M, Arastehfar A (2023) Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap. Lancet Microbe 4(6):e470\u2013e480. https:\/\/doi.org\/10.1016\/S2666-5247(23)00067-8","journal-title":"Lancet Microbe"},{"issue":"3","key":"2085_CR8","doi-asserted-by":"publisher","first-page":"1010782","DOI":"10.3389\/ffunb.2022.1010782","volume":"24","author":"P Escribano","year":"2022","unstructured":"Escribano P, Guinea J (2022) Fluconazole-resistant candida parapsilosis: a new emerging threat in the fungi arena. Front Fungal Biol 24(3):1010782","journal-title":"Front Fungal Biol"},{"issue":"7\u20138","key":"2085_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1046\/j.1439-0507.2000.00587.x","volume":"43","author":"K Fekete-Forg\u00e1cs","year":"2000","unstructured":"Fekete-Forg\u00e1cs K, Gy\u00fcre L, Lenkey B (2000) Changes of virulence factors accompanying the phenomenon of induced fluconazole resistance in Candida albicans. Mycoses 43(7\u20138):273\u2013279. https:\/\/doi.org\/10.1046\/j.1439-0507.2000.00587.x","journal-title":"Mycoses"},{"issue":"10","key":"2085_CR10","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/jof8101077","volume":"8","author":"S Fioriti","year":"2022","unstructured":"Fioriti S, Brescini L, Pallotta F, Canovari B, Morroni G, Barchiesi F (2022) Antifungal combinations against Candida species: From bench to bedside. J Fungi 8(10):1077. https:\/\/doi.org\/10.3390\/jof8101077","journal-title":"J Fungi"},{"key":"2085_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-024-03213-8","author":"ZA Hefny","year":"2024","unstructured":"Hefny ZA, Ji B, Elsemman IE, Nielsen J, Van Dijck P (2024) Transcriptomic meta-analysis to identify potential antifungal targets in Candida albicans. BMC Microbiol. https:\/\/doi.org\/10.1186\/s12866-024-03213-8","journal-title":"BMC Microbiol"},{"key":"2085_CR12","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1086\/422329","volume":"190","author":"W Huang","year":"2004","unstructured":"Huang W, Na L, Fidel PL, Schwarzenberger P (2004) Requirement of interleukin-17A for systemic anti- Candida albicans host defense in mice. J Infect Dis 190:624\u2013631","journal-title":"J Infect Dis"},{"key":"2085_CR13","doi-asserted-by":"publisher","first-page":"1531543","DOI":"10.3389\/fmicb.2025.1531543","volume":"16","author":"X Huang","year":"2025","unstructured":"Huang X, Dong Q, Zhou Q, Shitao F, Yiheng X, Hongjie L, Jingyi C, Xiao L, Huaguang Q, Dan M, Xunchao C (2025) Genomic insights of candidiasis: mechanisms of pathogenicity and drug resistance. Front Microbiol 16:1531543. https:\/\/doi.org\/10.3389\/fmicb.2025.1531543","journal-title":"Front Microbiol"},{"key":"2085_CR14","unstructured":"Invasive Candidiasis|Candidiasis|Types of Fungal Diseases|Fungal Diseases|CDC. www.cdc.gov. Retrieved 2017-04-02."},{"issue":"8","key":"2085_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/intimm\/dxac019","volume":"34","author":"MT Iwasawa","year":"2022","unstructured":"Iwasawa MT, Miyachi H, Wakabayashi S, Sugihira T, Aoyama R, Nakagawa S, Katayama Y, Yoneyama M, Hara H, Iwakura Y, Matsumoto M, Inohara N, Koguchi-Yoshioka H, Fujimoto M, N\u00fa\u00f1ez G, Matsue H, Nakamura Y, Saijo S (2022) Epidermal clearance of Candida albicans is mediated by IL-17 but independent of fungal innate immune receptors. Int Immunol 34(8):409\u2013420. https:\/\/doi.org\/10.1093\/intimm\/dxac019","journal-title":"Int Immunol"},{"key":"2085_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae646","author":"SE Jacobs","year":"2024","unstructured":"Jacobs SE, Chaturvedi V (2024) CAF to the rescue potential and challenges of combination antifungal therapy for reducing morbidity and mortality in Hospitalized patients with serious fungal infections. Open Forum Infect Dis. https:\/\/doi.org\/10.1093\/ofid\/ofae646","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"2085_CR17","doi-asserted-by":"publisher","first-page":"e131046","DOI":"10.5812\/jjm-131046","volume":"15","author":"Z Jahanshiri","year":"2022","unstructured":"Jahanshiri Z, Manifar S, Arastehnazar F, Hatami F, Lotfali E (2022) Azole Resistance in Candida albicans Isolates from oropharyngeal candidiasis is associated with ERG11 mutation and efflux overexpression. Jundishapur J Microbiol 15(9):e131046. https:\/\/doi.org\/10.5812\/jjm-131046","journal-title":"Jundishapur J Microbiol"},{"key":"2085_CR18","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2023.255","author":"E Jenkins","year":"2023","unstructured":"Jenkins E, Lyman M, Jackson B, Lockhart S, Wolford H, Reddy S, Baggs J (2023) Fluconazole resistance in non-albicans Candida species in the United States, 2012\u20132021. Antimicrob Steward Healthc Epidemiol. https:\/\/doi.org\/10.1017\/ash.2023.255","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"2","key":"2085_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12281-010-0018-6","volume":"4","author":"MD Johnson","year":"2010","unstructured":"Johnson MD, Perfect JR (2010) Use of Antifungal combination therapy: agents, order, and timing. Curr Fungal Infect Rep 4(2):87\u201395. https:\/\/doi.org\/10.1007\/s12281-010-0018-6","journal-title":"Curr Fungal Infect Rep"},{"key":"2085_CR20","doi-asserted-by":"publisher","first-page":"940884","DOI":"10.3389\/ffunb.2022.940884","volume":"3","author":"B Jungnickel","year":"2022","unstructured":"Jungnickel B, Jacobsen ID (2022) Systemic Candidiasis in Mice: New Insights From an Old Model. Frontiers in Fungal Biology 3:940884. https:\/\/doi.org\/10.3389\/ffunb.2022.940884","journal-title":"Frontiers in Fungal Biology"},{"issue":"11(8)","key":"2085_CR21","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3390\/jof11080603","volume":"19","author":"I Kilbas","year":"2025","unstructured":"Kilbas I, Kahraman Kilbas EP, Horhat FG, Ciftci IH (2025) Twenty-year course of antifungal resistance in Candida albicans in T\u00fcrkiye: a systematic review and meta-analysis. J Fungi 19(11(8)):603","journal-title":"J Fungi"},{"issue":"2","key":"2085_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/s0732-8893(99)00125-x","volume":"36","author":"RE Lewis","year":"2000","unstructured":"Lewis RE, Klepser ME, Pfaller MA (2000) In vitro pharmacodynamic characteristics of flucytosine determined by time-kill methods. Diagn Microbiol Infect Dis 36(2):101\u2013105. https:\/\/doi.org\/10.1016\/s0732-8893(99)00125-x","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2085_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlaf106","author":"Y Li","year":"2025","unstructured":"Li Y, Hind C, Furner-Pardoe J, Sutton JM, Rahman KM (2025) Understanding the mechanisms of resistance to azole antifungals in Candida species. JAC Antimicrob Resist. https:\/\/doi.org\/10.1093\/jacamr\/dlaf106","journal-title":"JAC Antimicrob Resist"},{"issue":"2","key":"2085_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000321157","volume":"3","author":"MS Lionakis","year":"2011","unstructured":"Lionakis MS, Lim JK, Lee CC, Murphy PM (2011) Organ-specific innate immune responses in a mouse model of invasive candidiasis. J Innate Immun 3(2):180\u2013199. https:\/\/doi.org\/10.1159\/000321157","journal-title":"J Innate Immun"},{"issue":"1","key":"2085_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC (2003) Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chem 52(1):1. https:\/\/doi.org\/10.1093\/jac\/dkg301","journal-title":"J Antimicrob Chem"},{"issue":"7","key":"2085_CR27","doi-asserted-by":"publisher","first-page":"e00584","DOI":"10.1128\/AAC.00584-17.PMID:28461316;PMCID:PMC5487674","volume":"61","author":"C Popp","year":"2017","unstructured":"Popp C, Hampe IAI, Hertlein T, Ohlsen K, Rogers PD, Morschh\u00e4user J (2017) Competitive fitness of fluconazole-resistant clinical Candida albicans Strains. Antimicrob Agents Chemother 61(7):e00584-e617. https:\/\/doi.org\/10.1128\/AAC.00584-17.PMID:28461316;PMCID:PMC5487674","journal-title":"Antimicrob Agents Chemother"},{"key":"2085_CR28","doi-asserted-by":"publisher","unstructured":"Puerta-Arias JD, Mej\u00b4\u0131a SP, Gonza\u00b4 lez A\u00b4 (2020) The Role of the Interleukin-17 Axis and Neutrophils in the Pathogenesis of Endemic and Systemic Mycoses. Front Cell Infect Microbiol. 10:595301. https:\/\/doi.org\/10.3389\/fcimb.2020.595301.","DOI":"10.3389\/fcimb.2020.595301"},{"issue":"10","key":"2085_CR29","first-page":"1077","volume":"9","author":"AM Rauseo","year":"2023","unstructured":"Rauseo AM, Spec A, Powderly WG (2023) Antifungal combinations against Candida species: current evidence and future directions. J Fungi. 9(10):1077","journal-title":"J Fungi."},{"issue":"1","key":"2085_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/jof4010021","volume":"4","author":"E Segal","year":"2018","unstructured":"Segal E, Frenkel M (2018) Experimental in Vivo Models of Candidiasis. J Fungi (Basel) 4(1):21. https:\/\/doi.org\/10.3390\/jof4010021","journal-title":"J Fungi (Basel)"},{"issue":"7","key":"2085_CR31","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/jac\/dkad139","volume":"78","author":"A Soriano","year":"2023","unstructured":"Soriano A, Honore PM, Puerta-Alcalde P, Garcia-Vidal C, Pagotto A, Gon\u00e7alves-Bradley DC, Verweij PE (2023) Invasive candidiasis: current clinical challenges and unmet needs in adult populations. J Antimicrob Chemother 78(7):1569\u20131585. https:\/\/doi.org\/10.1093\/jac\/dkad139","journal-title":"J Antimicrob Chemother"},{"key":"2085_CR32","doi-asserted-by":"publisher","first-page":"1480808","DOI":"10.3389\/fmicb.2024.1480808","volume":"15","author":"C Sun","year":"2024","unstructured":"Sun C, Zhu L, Yang L, Tian Z, Jiao Z, Huang M, Peng J, Guo G (2024) Antimicrobial peptide AMP-17 induces protection against systemic candidiasis and interacts synergistically with fluconazole against Candida albicans biofilm. Front Microbiol 15:1480808. https:\/\/doi.org\/10.3389\/fmicb.2024.1480808","journal-title":"Front Microbiol"},{"issue":"1","key":"2085_CR33","doi-asserted-by":"publisher","first-page":"2559024","DOI":"10.1080\/20002297.2025.2559024","volume":"17","author":"P Suwannaphong","year":"2025","unstructured":"Suwannaphong P, Thammasit P, Amsri A, Ueangphairot W, Muangwong P, Kittidachanan K, Chitapanarux I, Kantapan J, Dechsupa N, Youngchim S (2025) Fluconazole tolerance and virulence adaptations of Candida albicans isolated from head and neck cancer patients. J Oral Microbiol 17(1):2559024","journal-title":"J Oral Microbiol"},{"key":"2085_CR34","doi-asserted-by":"publisher","first-page":"1397539","DOI":"10.3389\/fmed.2024.1397539","volume":"11","author":"Q Teng","year":"2024","unstructured":"Teng Q, Ye X, Wang B, Zhang X, Tao Z, Yin X, Yang Q (2024) Case report: successful combination therapy with isavuconazole and amphotericin B in treatment of disseminated Candida tropicalis infection. Front Medicine 11:1397539","journal-title":"Front Medicine"},{"key":"2085_CR35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/SHK.0b013e3181d67041","volume":"34","author":"FL Van de Veerdonk","year":"2010","unstructured":"Van de Veerdonk FL (2010) Differential effects of IL-17 pathway in disseminated candidiasis and zymosan-induced multiple organ failure. Shock 34:407\u2013411","journal-title":"Shock"},{"issue":"9","key":"2085_CR36","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3390\/jof7090731","volume":"7","author":"RG Vitale","year":"2021","unstructured":"Vitale RG (2021) Role of antifungal combinations in difficult to treat candida infections. J Fungi (Basel) 7(9):731. https:\/\/doi.org\/10.3390\/jof7090731","journal-title":"J Fungi (Basel)"},{"key":"2085_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae072","author":"RM Wake","year":"2024","unstructured":"Wake RM, Allebone-Salt PE, John LLH, Caswall BA, Govender NP, Ben-Ami R, Murray LW, Logan C, Harrison TS, Bicanic TA (2024) Optimizing the treatment of invasive candidiasis-a case for combination therapy. Open Forum Infect Dis 11(6):ofae072. https:\/\/doi.org\/10.1093\/ofid\/ofae072","journal-title":"Open Forum Infect Dis"},{"key":"2085_CR38","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173.PMID:28127295;PMCID:PMC5226953","volume":"7","author":"SG Whaley","year":"2017","unstructured":"Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS, Rogers PD (2017) Azole antifungal resistance in Candida albicans and emerging non-Albicans Candida species. Front Microbiol 7:2173. https:\/\/doi.org\/10.3389\/fmicb.2016.02173.PMID:28127295;PMCID:PMC5226953","journal-title":"Front Microbiol"},{"key":"2085_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.3MA0120-325RR","author":"J Wu","year":"2020","unstructured":"Wu J, Wu D, Ma K, Wang T, Shi G, Shao J, Wang C, Yan G (2020) Paeonol ameliorates murine alcohol liver disease via mycobiota-mediated Dectin-1\/IL-1\u03b2 signaling pathway. J Leukoc Biol. https:\/\/doi.org\/10.1002\/JLB.3MA0120-325RR","journal-title":"J Leukoc Biol"},{"issue":"1","key":"2085_CR40","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12866-024-03512-0","volume":"24","author":"H Zeitoun","year":"2024","unstructured":"Zeitoun H, Salem RA, El-Guink NM, Tolba NS, Mohamed NM (2024) Elucidation of the mechanisms of fluconazole resistance and repurposing treatment options against urinary spp. isolated from hospitalized patients in Alexandria. Egypt. BMC Microbiology 24(1):383","journal-title":"Egypt. BMC Microbiology"},{"key":"2085_CR41","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12879-015-1086-6.","volume":"15","author":"L Zhang","year":"2015","unstructured":"Zhang L, Xiao M, Watts MR, Wang H, Fan X, Kong F, Xu YC (2015) Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy. BMC Infect Dis 15:340. https:\/\/doi.org\/10.1186\/s12879-015-1086-6.","journal-title":"BMC Infect Dis"}],"container-title":["AMB Express"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13568-026-02085-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-026-02085-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-026-02085-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:52:10Z","timestamp":1790898730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13568-026-02085-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2085"],"URL":"https:\/\/doi.org\/10.1186\/s13568-026-02085-7","relation":{},"ISSN":["2191-0855"],"issn-type":[{"value":"2191-0855","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were conducted in compliance with ethical guidelines and national standards for medical research in Iran, under approval number: IR.PII.AEC.1401.011.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"100"}}